VCYT
Veracyte Inc
NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$39.70
-2.42% today
Updated 2026-06-05
Market cap
$3.78B
P/E ratio
43.82
P/S ratio
6.97x
EPS (TTM)
$1.08
Dividend yield
—
52W range
$23 – $51
Volume
1.0M
Veracyte Inc (VCYT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$39.70
12-Month target
$25.71
2030 Target
—
Intrinsic (DCF)
$86.39
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.4B | $0.4B | $0.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 16.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.